UnitedHealth Group Incorporated (UNH) Position Boosted by Bank of Montreal Can
Bank of Montreal Can raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.9% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,919,070 shares of the healthcare conglomerate’s stock after buying an additional 485,532 shares during the quarter. Bank of Montreal Can owned about 0.20% of UnitedHealth Group worth $355,834,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC grew its position in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares in the last quarter. Kings Point Capital Management grew its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management purchased a new position in UnitedHealth Group during the first quarter worth about $135,000. Parkside Financial Bank & Trust grew its position in UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares in the last quarter. Finally, Hanson McClain Inc. grew its position in UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after buying an additional 15 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) traded down 3.25% on Friday, reaching $188.86. The company’s stock had a trading volume of 2,208,807 shares. The company has a market capitalization of $182.60 billion, a PE ratio of 22.69 and a beta of 0.63. UnitedHealth Group Incorporated has a one year low of $133.03 and a one year high of $200.76. The firm has a 50-day moving average of $195.56 and a 200-day moving average of $181.26.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.96 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.53%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s payout ratio is currently 35.13%.
In other news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. In the last three months, insiders sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is owned by insiders.
UNH has been the subject of several research analyst reports. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, May 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a research note on Friday, July 21st. Vetr raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price target for the company in a research note on Tuesday, May 30th. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $205.00 price target (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $203.59.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Watch List News and is the property of of Watch List News. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-position-boosted-by-bank-of-montreal-can/1580850.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.